Translational Oncology (Mar 2022)

Corrigendum to “PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor” [Volume 14, Issue 9, September 2021, 101152]

  • Satoko Koga,
  • Hideya Onishi,
  • Shogo Masuda,
  • Akiko Fujimura,
  • Shu Ichimiya,
  • Kazunori Nakayama,
  • Akira Imaizumi,
  • Kenichi Nishiyama,
  • Masayuki Kojima,
  • Kei Miyoshi,
  • Katsuya Nakamura,
  • Masayo Umebayashi,
  • Takashi Morisaki,
  • Masafumi Nakamurab

Journal volume & issue
Vol. 17
p. 101344

Abstract

Read online

No abstracts available.